RE:RE:newsi did some digging and this is what I found. Hope it makes sense: "biological asset rule credits the value of product that is growing at fair value minus selling costs and reports that figure on the income statement.
The changes in fair value are not counted as revenue, but as a reduction in the cost of sales, which as a result boosts the bottom line.
That means a company can report net income in a quarter in which they grew or harvested marijuana, but had no sales to speak of."
I don't know if it provides any clarity but for me it certainly explains yesterdays movement.